These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

621 related articles for article (PubMed ID: 27434881)

  • 1. The cancer stem-cell signaling network and resistance to therapy.
    Carnero A; Garcia-Mayea Y; Mir C; Lorente J; Rubio IT; LLeonart ME
    Cancer Treat Rev; 2016 Sep; 49():25-36. PubMed ID: 27434881
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Advances in Therapeutic Targeting of Cancer Stem Cells within the Tumor Microenvironment: An Updated Review.
    Dzobo K; Senthebane DA; Ganz C; Thomford NE; Wonkam A; Dandara C
    Cells; 2020 Aug; 9(8):. PubMed ID: 32823711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Insights into new mechanisms and models of cancer stem cell multidrug resistance.
    Garcia-Mayea Y; Mir C; Masson F; Paciucci R; LLeonart ME
    Semin Cancer Biol; 2020 Feb; 60():166-180. PubMed ID: 31369817
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cancer stem cell (CSC) resistance drivers.
    Najafi M; Mortezaee K; Majidpoor J
    Life Sci; 2019 Oct; 234():116781. PubMed ID: 31430455
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting cancer stem cell-specific markers and/or associated signaling pathways for overcoming cancer drug resistance.
    Ranji P; Salmani Kesejini T; Saeedikhoo S; Alizadeh AM
    Tumour Biol; 2016 Oct; 37(10):13059-13075. PubMed ID: 27561758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms.
    Cojoc M; Mäbert K; Muders MH; Dubrovska A
    Semin Cancer Biol; 2015 Apr; 31():16-27. PubMed ID: 24956577
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Therapy resistance mediated by cancer stem cells.
    Steinbichler TB; Dudás J; Skvortsov S; Ganswindt U; Riechelmann H; Skvortsova II
    Semin Cancer Biol; 2018 Dec; 53():156-167. PubMed ID: 30471331
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Targeting autophagy in cancer stem cells as an anticancer therapy.
    Lei Y; Zhang D; Yu J; Dong H; Zhang J; Yang S
    Cancer Lett; 2017 May; 393():33-39. PubMed ID: 28216370
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Emerging functional markers for cancer stem cell-based therapies: Understanding signaling networks for targeting metastasis.
    Marquardt S; Solanki M; Spitschak A; Vera J; Pützer BM
    Semin Cancer Biol; 2018 Dec; 53():90-109. PubMed ID: 29966677
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cancer stem cell epigenetics and chemoresistance.
    Crea F; Danesi R; Farrar WL
    Epigenomics; 2009 Oct; 1(1):63-79. PubMed ID: 22122637
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cancer Stem Cells: Root of the Evil.
    Erkisa M; Karakas D; Ulukaya E
    Crit Rev Oncog; 2019; 24(1):69-87. PubMed ID: 31679222
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cancer stem cells.
    Yu Z; Pestell TG; Lisanti MP; Pestell RG
    Int J Biochem Cell Biol; 2012 Dec; 44(12):2144-51. PubMed ID: 22981632
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistance to Cell Death and Its Modulation in Cancer Stem Cells.
    Safa AR
    Crit Rev Oncog; 2016; 21(3-4):203-219. PubMed ID: 27915972
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug Resistance Driven by Cancer Stem Cells and Their Niche.
    Prieto-Vila M; Takahashi RU; Usuba W; Kohama I; Ochiya T
    Int J Mol Sci; 2017 Dec; 18(12):. PubMed ID: 29194401
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Approaches to Targeting Cancer Stem Cells in Solid Tumors.
    Caldas-Lopes E; Gomez-Arteaga A; Guzman ML
    Curr Stem Cell Res Ther; 2019; 14(5):421-427. PubMed ID: 30806324
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Potential mechanisms of CD133 in cancer stem cells.
    Jang JW; Song Y; Kim SH; Kim J; Seo HR
    Life Sci; 2017 Sep; 184():25-29. PubMed ID: 28697984
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer stem cells: the 'Achilles heel' of chemo-resistant tumors.
    Hong IS; Lee HY; Nam JS
    Recent Pat Anticancer Drug Discov; 2015; 10(1):2-22. PubMed ID: 25479037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Tackling multidrug resistance mediated by efflux transporters in tumor-initiating cells.
    McIntosh K; Balch C; Tiwari AK
    Expert Opin Drug Metab Toxicol; 2016 Jun; 12(6):633-44. PubMed ID: 27116192
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tumor dormancy and cancer stem cells: two sides of the same coin?
    Kleffel S; Schatton T
    Adv Exp Med Biol; 2013; 734():145-79. PubMed ID: 23143979
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 32.